Guidelines for the management of growth failure in childhood inflammatory bowel disease.
about
Optimizing the Care and Health of Women with Inflammatory Bowel DiseaseTransitioning the Adolescent with IBD from Pediatric to Adult Care: A Review of the LiteratureCrohn's disease and growth deficiency in children and adolescentsIndications and surgical options for small bowel, large bowel and perianal Crohn's diseaseInflammatory Bowel Disease in Children and AdolescentsReview article: diet and inflammatory bowel disease--epidemiology and treatment.Emerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature.Effect of exclusion diet with nutraceutical therapy in juvenile Crohn's disease.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.Nutritional status and growth in Korean children with Crohn's disease: a single-center studyBudesonide in the treatment of inflammatory bowel disease.Growth problems in children with IBD.Assessment of bone remodelling in childhood-onset systemic lupus erythematosus.Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.The Emerging Adult with Inflammatory Bowel Disease: Challenges and Recommendations for the Adult GastroenterologistA snapshot of the nutritional status of Crohn's disease among adolescents in Brazil: a prospective cross-sectional study.Assessment of Sex Differences for Treatment, Procedures, Complications, and Associated Conditions Among Adolescents Hospitalized with Crohn's Disease.Characteristics of Pediatric Crohn's Disease in Saudi Children: A Multicenter National Study.Urinary Metabolic Phenotyping Reveals Differences in the Metabolic Status of Healthy and Inflammatory Bowel Disease (IBD) Children in Relation to Growth and Disease Activity.Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations.Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel diseaseLong-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's DiseaseNutritional considerations in pediatric inflammatory bowel disease.Use of immunomodulators and biologic therapies in children with inflammatory bowel disease.Antitumor necrosis factor treatment for pediatric inflammatory bowel disease.History of and current issues affecting surgery for pediatric ulcerative colitis.Toxicological assessment of drugs that affect the endocrine system in puberty-related disorders.Endocrine therapy for growth retardation in paediatric inflammatory bowel disease.Adalimumab for the treatment of pediatric Crohn's disease.Nutritional aspect of pediatric inflammatory bowel disease: its clinical importance.Japanese physicians' attitudes towards enteral nutrition treatment for pediatric patients with Crohn's disease: a questionnaire survey.Intestinal inflammation without weight loss decreases bone density and growth.Inflammatory bowel disease in children of middle eastern descent.KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ productionUrinary metabolic insights into host-gut microbial interactions in healthy and IBD children.Endocrine and metabolic manifestations in inflammatory bowel diseaseLaparoscopic adult colorectal surgeon and adolescents with inflammatory bowel disease: a safe combination?Endocrine impact of Helicobacter pylori: focus on ghrelin and ghrelin o-acyltransferaseGrowth parameters early in the course of pediatric inflammatory bowel disease.
P2860
Q26830487-6A656DC1-0AAC-4FAF-9A26-A4AC65CA2FCBQ26853297-9D496AAD-3BD8-464C-959E-FC20AA532C8FQ26865160-065E12EF-1807-4B97-AF2E-9C8715A5CA1CQ28079926-A6E7C5D5-5D30-4475-B4D7-1B9420BD0B35Q30695348-0A855B13-FD99-4E8A-BDB9-C4A1A93A6405Q33445163-C1220989-8A6E-439A-9D62-2EAC2EB479AEQ33916303-D3D23181-EAB2-4505-A59C-3889F7AE6A67Q34098363-46934CD8-63C9-4444-A127-22B30EFC3273Q34152778-4C34D2B0-791E-46AD-95F3-51D489B40F21Q34182085-575B0D88-0B31-4B1D-AFB3-E3060D34F212Q34203594-35F2DE3A-46DC-4C58-A8EB-2680F22EDC7DQ34426164-4652E9AD-3990-4427-B087-438E290B1923Q34588979-E9CAF5D5-60B2-4174-9EEC-57B20722ED83Q35106293-E1112625-FC37-4876-94C5-D5B7A7CBF2DBQ35614324-AFCBBF6B-FA54-4298-A7AB-16A82E3C6255Q35862736-9E15A64C-88A3-4A07-B81D-BC5401123B96Q36219178-44C396DA-6CA7-4ED1-A286-1B4FBA591B9FQ36453521-4005E429-5259-4C26-9FD1-8E1D156F6CFBQ37210128-5E145A88-799B-438A-B48D-AFD3455E7A91Q37397341-D6D9A520-EE3F-400F-98F8-FC0E7AC68105Q37492482-5C5C8BA0-90C8-4464-8ADD-85F785BE335AQ37609746-35452D4F-4895-4652-9877-869B379CAE56Q37656048-7B70D91D-9580-44F6-BB67-4850F598FB89Q37763081-3539339D-C494-4CCC-8AF2-15A4FB41FAAAQ37769253-B506360F-09A3-40F7-85B9-6E0CCA7DE8BBQ37936394-B10EC567-B7C2-47B2-8DFE-53C9B16E4C4DQ38064356-5F9CD762-9944-49F4-8B48-25C9964ECD27Q38116106-7FCECE9E-F4AA-4731-97EA-581651B05E4FQ38137812-53541C4F-B758-40F5-AF3E-1C7036C50A3CQ38554433-12CF2B6C-9812-4695-B887-46A5242E8E5DQ38635666-88F6F7C6-7942-40F4-A3C3-89DE82BE8746Q38697542-DCA91333-295F-4162-B721-2A268BEB5A79Q38812259-14C97BDF-940B-4D5B-BC18-8C66E800E158Q40791753-32CD554A-DDA1-462C-BF43-7652EB8C6598Q41417837-B6B277CD-67FD-4BD0-9D25-5B801C83AB00Q42237462-68B5FF41-D345-479D-B588-FC6B19CE0CD6Q42406756-88DE2C7F-E39B-4E0B-B881-99D67B7EAA55Q42677610-BFF27AB3-EC57-43FB-B77C-535257BF47B9Q42707610-C6C5EFB5-1688-42B5-A6A9-29A7A63F6B41Q42921726-3B0FF5A8-809D-425A-8F20-9C34980996AC
P2860
Guidelines for the management of growth failure in childhood inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guidelines for the management of growth failure in childhood inflammatory bowel disease.
@en
Guidelines for the management of growth failure in childhood inflammatory bowel disease.
@nl
type
label
Guidelines for the management of growth failure in childhood inflammatory bowel disease.
@en
Guidelines for the management of growth failure in childhood inflammatory bowel disease.
@nl
prefLabel
Guidelines for the management of growth failure in childhood inflammatory bowel disease.
@en
Guidelines for the management of growth failure in childhood inflammatory bowel disease.
@nl
P2093
P2860
P356
P1476
Guidelines for the management of growth failure in childhood inflammatory bowel disease.
@en
P2093
Anne Griffiths
Camilla Salvestrini
Hans Hildebrand
R Mark Beattie
Robert Heuschkel
Thomas Walters
P2860
P304
P356
10.1002/IBD.20378
P577
2008-06-01T00:00:00Z